Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wells Fargo analyst Michael Turrin maintains Braze (NASDAQ:BRZE) with a Overweight and lowers the price target from $75 to $65.
Canaccord Genuity analyst David Hynes maintains Braze (NASDAQ:BRZE) with a Buy and lowers the price target from $65 to $50.
Piper Sandler analyst Brent Bracelin maintains Braze (NASDAQ:BRZE) with a Overweight and maintains $66 price target.
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...
Braze shares down after soft EPS guidance for Q1 and FY25. Yesterday, the company reported a fourth-quarter FY24 EPS loss of $(...
Raymond James analyst Brian Peterson maintains Braze (NASDAQ:BRZE) with a Outperform and lowers the price target from $75 to...
TD Cowen analyst J. Derrick Wood maintains Braze (NASDAQ:BRZE) with a Buy and lowers the price target from $68 to $65.
